RESUMEN
The potential environmental risk associated with flowback waters generated during hydraulic fracturing of target shale gas formations needs to be assessed to enable management decisions and actions that prevent adverse impacts on aquatic ecosystems. Using direct toxicity assessment (DTA), we determined that the shale gas flowback wastewater (FWW) from two exploration wells (Tanumbirini-1 and Kyalla 117 N2) in the Beetaloo Sub-basin, Northern Territory, Australia were chronically toxic to eight freshwater biota. Salinity in the respective FWWs contributed 16% and 55% of the chronic toxicity at the 50% effect level. The remaining toxicity was attributed to unidentified chemicals and interactive effects from the mixture of identified organics, inorganics and radionuclides. The most sensitive chronic endpoints were the snail (Physa acuta) embryo development (0.08-1.1% EC10), microalga (Chlorella sp. 12) growth rate inhibition (0.23-3.7% EC10) and water flea (Ceriodaphnia cf. dubia) reproduction (0.38-4.9% EC10). No effect and 10% effect concentrations from the DTA were used in a species sensitivity distribution to derive "safe" dilutions of 1 in 300 and 1 in 1140 for the two FWWs. These dilutions would provide site-specific long-term protection to 95% of aquatic biota in the unlikely event of an accidental spill or seepage.
Asunto(s)
Chlorella , Fracking Hidráulico , Contaminantes Químicos del Agua , Ecosistema , Agua Dulce , Gas Natural , Yacimiento de Petróleo y Gas , Salinidad , Aguas Residuales , Contaminantes Químicos del Agua/análisis , Contaminantes Químicos del Agua/toxicidadRESUMEN
Pharmaceuticals, which are designed to be biologically active at low concentrations, are found in surface waters, meaning aquatic organisms can be exposed to complex mixtures of pharmaceuticals. In this study, the adverse effects of four pharmaceuticals, 17α-ethynylestradiol (synthetic estrogen), methotrexate (anticancer drug), diclofenac (nonsteroidal anti-inflammatory drug) and fluoxetine (antidepressant), and their binary mixtures at mg/L concentrations were assessed using the 7-day Lemna minor test, with both apical and biochemical markers evaluated. The studied biochemical markers included chlorophyll a, chlorophyll b, carotenoids and oxidative stress enzymes catalase, glutathione-S-transferase and glutathione reductase, with effects compared to solvent controls. The adverse effects on Lemna minor were dose-dependent for frond number, surface area, relative chlorophyll content and activity of glutathione S-transferase for both individual pharmaceuticals and binary mixtures. According to the individual toxicity values, all tested pharmaceuticals can be considered as toxic or harmful to aquatic organisms, with methotrexate considered highly toxic. The most sensitive endpoints for the binary mixtures were photosynthetic pigments and frond surface area, with effects observed in the low mg/L concentration range. The concentration addition model and toxic unit approach gave similar mixture toxicity predictions, with binary mixtures of methotrexate and fluoxetine or methotrexate and 17α-ethynylestradiol exhibiting synergistic effects. In contrast, mixtures of diclofenac with fluoxetine, 17α-ethynylestradiol or methotrexate mostly showed additive effects. While low concentrations of methotrexate are expected in surface water, chronic ecotoxicological data for invertebrates and fish are lacking, but this is required to better assess the environmental risk of methotrexate.
Asunto(s)
Araceae/fisiología , Preparaciones Farmacéuticas , Contaminantes Químicos del Agua/toxicidad , Animales , Organismos Acuáticos/efectos de los fármacos , Araceae/efectos de los fármacos , Catalasa/metabolismo , Clorofila A , Diclofenaco/toxicidad , Ecotoxicología , Fotosíntesis/efectos de los fármacosRESUMEN
The manufacturing and consumption of drugs of addiction has increased globally and their widespread occurrence in the environment is an emerging concern. This study evaluated the phytotoxicity of three compounds: methamphetamine, codeine and morphine; commonly reported in Australian urban water, to the aquatic plant Lemna minor under controlled conditions. L. minor was sensitive to lower drug concentrations when administered in multi-compound mixtures (100-500 µg L-1) than when applied individually (range 600-2500 µg L-1), while no adverse effects were observed at environmentally-relevant concentrations (1-5 µg L-1) detected in wastewater effluent. In conclusion, the results show that the concentrations of these compounds discharged into the environment are unlikely to pose adverse phytotoxic effects. These three compounds are known to be the most stable of their group under such conditions indicating that with this respect it is safe to use recycled water for existing regulated reclaimed purposes including agricultural or parklands irrigation or replenishing surface and groundwater. However, more research on the analysis of methamphetamines and opiates in municipal effluents is needed to reassure the likely environmental hazard of these neuroactive drug classes to aquatic organisms. Given the ever-growing production and aquatic disposal of discharge wastewater globally, this study provides timely and valuable insights into the likely drug-related impacts of effluent disposal on aquatic plants in receiving environments.
Asunto(s)
Araceae/efectos de los fármacos , Codeína/toxicidad , Drogas Ilícitas/toxicidad , Metanfetamina/toxicidad , Morfina/toxicidad , Contaminantes Químicos del Agua/toxicidad , Riego Agrícola , Australia , Codeína/análisis , Relación Dosis-Respuesta a Droga , Monitoreo del Ambiente , Drogas Ilícitas/análisis , Metanfetamina/análisis , Morfina/análisis , Reciclaje , Aguas Residuales/química , Contaminantes Químicos del Agua/análisisRESUMEN
Acute and chronic bioassays provide essential basis for establishment of environmental quality standards. The effects of Cu on a pulmonate snail, Physa acuta, were investigated at a number of sublethal and lethal endpoints. Cu exposure suppressed movement and triggered an escape response in P. acuta at low and high concentrations, respectively, exerting acute toxic effects on adult snails exposed to a 96 h LC50 of 23.8 µg L-1. Following 16 d exposure of Cu to the egg masses, successful hatching decreased with increasing Cu concentration. High Cu concentrations (12.5 and 25 µg L-1) resulted in inhibition of eye and shell development at the veliger stage, and a deformed shell, abnormal eyes, and different morphological shapes with lesions and hemorrhages were observed after 9 days of exposure. A large number of eggs exposed to 2.5-25 µg L-1 Cu remained in the veliger and hippo stages for 2-7 days, with no further development. Results from reproduction tests showed that adult snails exposed to various Cu treatments produced more than three broods, with the total number of eggs ranging from 770 to 1,289, revealing little difference between the control and Cu-treated groups (p > 0.05). However, snails exposed to 12.5 and 25 µg L-1 Cu produced polynuclear eggs in one egg capsule. The hatching success rate and shell length of the filial generation were significantly reduced in a dose-dependent manner (p < 0.05). The shell length of newly hatched snails was shorter in the reproduction test than in the hatching test, indicating inherent Cu toxicity in the filial generation from the exposed parent strain. The present study provides essential data regarding Cu toxicity in pulmonate snail P. acuta.
Asunto(s)
Cobre/toxicidad , Caracoles Helix/fisiología , Contaminantes Químicos del Agua/toxicidad , Animales , Reproducción/efectos de los fármacos , Caracoles/efectos de los fármacos , Pruebas de ToxicidadRESUMEN
Pharmaceuticals can enter freshwater and affect aquatic ecosystem health. Although toxicity tests have been carried out for the commonly used pharmaceuticals, evidence-based water quality guidelines have not been derived. High-reliability water quality guideline values have been derived for 4 pharmaceuticals-carbamazepine, diclofenac, fluoxetine, and propranolol-in freshwaters using a Burr type III distribution applied to species sensitivity distributions of chronic toxicity data. Data were quality-assured and had to meet acceptability criteria for "chronic" no-observed-effect concentrations or concentrations affecting 10% of species, endpoints of population relevance (namely, effect endpoints based on development, growth, reproduction, and survival). Biomarker response data (e.g., biochemical, histological, or molecular responses) were excluded from the derivation because they are typically not directly relevant to wildlife population-related impacts. The derived guideline values for 95% species protection were 9.2 µg/L, 770 µg/L, 1.6 µg/L, and 14 µg/L for carbamazepine, diclofenac, fluoxetine, and propranolol, respectively. These values are significantly higher than the unknown reliability values derived for the European Commission, Switzerland, or Germany that are based on the application of assessment factors to the most sensitive experimental endpoint (which may include biochemical, histological, or molecular biomarker responses) of a limited data set. The guideline values derived in the present study were not exceeded in recent data for Australian rivers and streams receiving pharmaceutical-containing effluents from wastewater-treatment plants. Environ Toxicol Chem 2016;35:1815-1824. © 2015 SETAC.